ReviewTherapeutic advances in hematology2013

From clinical trials to clinical practice: single-agent carfilzomib adverse events and their management in patients with relapsed and/or refractory multiple myeloma.

David S SiegelPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.